montreal bagel
Selected indexed studies
- Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis. (N Engl J Med, 2021) [PMID:34879448]
- A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. (Br J Dermatol, 2020) [PMID:31887225]
- FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis. (J Am Acad Dermatol, 2025) [PMID:39549848]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis. (2021) pubmed
- A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. (2020) pubmed
- FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis. (2025) pubmed
- Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort. (2023) pubmed
- Factors influencing alginate gel biocompatibility. (2011) pubmed
- The impact of transmission-ratio distortion on allele sharing in affected sibling pairs. (2000) pubmed
- Lack of association between bipolar disorder and tyrosine hydroxylase: a meta-analysis. (1997) pubmed
- Operative treatment of displaced midshaft clavicle fractures: has randomised control trial evidence changed practice patterns? (2019) pubmed
- MAOA: association and linkage studies with lithium responsive bipolar disorder. (1999) pubmed
- Polyglutamine coding genes in bipolar disorder: lack of association with selected candidate loci. (2000) pubmed